Aimei Health Technology Co., Ltd (AFJK)
Nasdaq: AFJK · Blank Checks · New York, NY · filing with the SEC since 2023
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | May 4, 2026 | Mar 28, 2025 | Mar 25, 2024 |
| Total costs and expenses | 835,759 | 1,064,786 | · |
| Operating income | -835,759 | -1,064,786 | · |
| Total non-operating income (expense) | 1,895,527 | 3,617,001 | · |
| Income tax expense | 0 | 0 | 0 |
| Net income | 1,059,768 | 2,552,215 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Total costs and expenses every operating cost, the cost of revenue included
us-gaap:OperatingCostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLoss